Celgene Corporation

(

CELG

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.1%. By the end of trading, Celgene Corporation rose 37 cents (0.6%) to $61.69 on average volume. Throughout the day, 3.4 million shares of Celgene Corporation exchanged hands as compared to its average daily volume of 3.7 million shares. The stock ranged in a price between $60.72-$62.05 after having opened the day at $60.98 as compared to the previous trading day's close of $61.32. Other companies within the Health Care sector that increased today were:

World Heart Corporation

(

WHRT

), up 22.9%,

Adeona Pharmaceuticals Inc

(

AEN

), up 19.1%,

ImmuCell Corporation

(

ICCC

), up 16%, and

Complete Genomics Inc

(

GNOM

), up 14.2%.

Celgene Corporation, an integrated biopharmaceutical company, discovers, develops, and commercializes various therapies to treat cancer and immune-inflammatory related diseases. Celgene Corporation has a market cap of $27.99 billion and is part of the

drugs

industry. The company has a P/E ratio of 26.5, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 3.7% year to date as of the close of trading on Monday.

TheStreet Ratings rates Celgene as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front,

Poniard Pharmaceuticals Inc

(

PARD

), down 25.4%,

Bionovo Inc

(

BNVI

), down 15.7%,

Spherix Inc

(

SPEXD

), down 10.9%, and

Spherix Inc

(

SPEX

), down 10.9%, were all losers within the health care sector with

GlaxoSmithKline

(

GSK

) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null